New Delhi: The expert panel of Drug Controller General of India (DCGI) on Thursday recommended that emergency use authorization be granted to the COVID-19 vaccine Corbevax for children in the age group of 5 to 12 years.
Corbevax, developed by Hyderabad-based firm Biological-E, is India’s first indigenously-developed RBD protein sub-unit vaccine against the coronavirus.
It is being administered to children in the age group of 12 to 14 from March 16, 2022.
Meanwhile, the government panel has sought more data from Bharat Biotech before granting emergency use approval to Covaxin among children aged 5-12.
The 5-12 age group is yet to brought under the nationwide inoculation drive.
Bhubaneswar: Police on Friday arrested eight persons including a minor boy who had gone on…
New Delhi: Stung by the latest notice served by Income Tax department on Friday, Congress…
Berhampur: Aska Lok Sabha constituency in Odisha's Ganjam district, the political birthplace of Chief Minister…
Mumbai: Clicking unusual selfies from risky positions have, at times, landed many in trouble. But this…
Bhubaneswar: The Commissionerate Police on Friday held a review meeting to draw up the strategy…
Bhubaneswar: Police have seized huge amount of explosive materials from a firecracker manufacturing unit in…
Cuttack: The Orissa High Court has extended the interim protection to BJD MLA and former…
New Delhi: The verbal duel between Trinamool Congress (TMC) and Bharatiya Janata Party (BJP) escalated…